4.7 Article

Survival analysis of mortality and development of lupus nephritis in patients with systemic lupus erythematosus up to 40 years of follow-up

Related references

Note: Only part of the references are listed.
Article Rheumatology

Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls

Irene E. M. Bultink et al.

Summary: Patients with SLE in the UK have a 1.8-fold increased mortality rate compared to the general population, with the highest risk for those aged 18-39 years old; low-dose HCQ reduces the risk of mortality by 45%.

RHEUMATOLOGY (2021)

Article Rheumatology

Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United Kingdom

Ana Lorenzo-Vizcaya et al.

Summary: This study provides a detailed analysis of causes of death, main characteristics, and trends in the management of deceased SLE patients over the past four decades at the UCLH lupus clinic. The main causes of death in the 40-year period were infection, cancer, and cardiovascular disease. Therapeutic developments such as the introduction of MMF and rituximab were noted, with an increase in the use of HCQ, MMF, and rituximab over time.

LUPUS (2021)

Article Rheumatology

Age differences in secular trends in black-white disparities in mortality from systemic lupus erythematosus among women in the United States from 1988 to 2017

Qianyu Guo et al.

Summary: The study found significant disparities in mortality rates from systemic lupus erythematosus (SLE) between black and white women, with black women having four to seven times higher SLE mortality rates than white women across different age groups. In contrast, black women had less than two times higher all-causes mortality rates than white women, and the disparities in all-causes mortality rates between black and white women significantly diminished over the past three decades.

LUPUS (2021)

Article Rheumatology

Assessing outcomes in a lupus nephritis cohort over a 40-year period

Eugeniu Gisca et al.

Summary: This study characterized a cohort of SLE patients over 40 years, analyzing changes in demographic, clinical, serological, and histological patterns. While there were shifts in ethnicity and disease characteristics, the 5-year mortality rates and progression to end-stage renal disease have stabilized in the last 20 years. New therapeutic approaches and strategies to enhance adherence are needed to further improve outcomes for SLE patients.

RHEUMATOLOGY (2021)

Article Public, Environmental & Occupational Health

Racial Disparities in Mortality Associated with Systemic Lupus Erythematosus - Fulton and DeKalb Counties, Georgia, 2002-2016

S. Sam Lim et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)

Article Rheumatology

The incidence and prevalence of systemic lupus erythematosus in the UK, 1999-2012

Frances Rees et al.

ANNALS OF THE RHEUMATIC DISEASES (2016)

Article Rheumatology

The Incidence and Prevalence of Systemic Lupus Erythematosus, 2002-2004

S. Sam Lim et al.

ARTHRITIS & RHEUMATOLOGY (2014)

Article Transplantation

Survival analysis and causes of mortality in patients with lupus nephritis

Desmond Y. H. Yap et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)

Article Rheumatology

Changing Patterns in Mortality and Disease Outcomes for Patients with Systemic Lupus Erythematosus

Murray B. Urowitz et al.

JOURNAL OF RHEUMATOLOGY (2008)

Article Rheumatology

Mortality in systemic lupus erythematosus

S. Bernatsky et al.

ARTHRITIS AND RHEUMATISM (2006)

Article Urology & Nephrology

The classification of glomerulonephritis in systemic lupus erythematosus revisited

JJ Weening et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)